文献速递胸部CT

筛查检出的肺大细胞癌:低剂量CT特征与生存分析

Large cell carcinoma of the lung: LDCT features and survival in screen-detected cases.
PubMed 文献 · Eur J Radiol · 2024-08-14

本研究联合复习NLST、ITALUNG和LUSI三项低剂量CT筛查试验中2002至2016年间共29744名受试者的资料,分析筛查检出的肺大细胞癌的影像特征与生存情况。结果显示大细胞癌占筛查检出肺癌的4%(30/750),多表现为单发、外周、边界清楚的实性结节或肿块,边缘光滑、分叶或毛刺,平均容积倍增时间98.7±47.8天,总体5年生存率50%,I-II期与III-IV期间差异显著(p=0.0001)。

要点

  • 筛查检出的大细胞癌多表现为单发、外周、边界清楚的实性结节或肿块,分叶状边缘最常见(43%)。
  • 在9例 incident 大细胞癌中,回顾既往低剂量CT可见较小实性结节,平均容积倍增时间为98.7±47.8天。
  • 总体5年生存率为50%,I-II期(存活75%)与III-IV期(存活10%)间差异显著(p=0.0001)。

核心结论

  • 大细胞癌是一种生长迅速的肿瘤,可能逃逸年度低剂量CT筛查的检出;其典型表现为单发、外周、边界清楚的实性结节或肿块,常伴分叶状边缘,容积倍增时间短;5年生存率反映诊断时的分期。

研究设计与样本

  • 研究类型为对NLST、ITALUNG和LUSI三项低剂量CT筛查试验中2002至2016年间筛查检出病例的影像学回顾分析,共纳入29744名接受3-5次年度筛查低剂量CT检查的受试者,由两名放射科医生共同复习影像特征,生存或死因依据随机化后超过12年的死亡登记确定。

关键影像表现/征象

  • 29例有低剂量CT图像的筛查检出大细胞癌中,28例表现为单发、外周、边界清楚的实性结节或肿块,边缘光滑者占39%、分叶状者占43%、毛刺状者占18%。
  • 1例表现为肺门肿块。
  • 在9例 incident 大细胞癌中,既往低剂量CT检查可见较小的实性结节,据此计算平均容积倍增时间为98.7±47.8天。

诊断标准与关键数值

  • 大细胞癌占筛查检出肺癌的4%(30/750),其中 prevalent 15例、incident 15例;筛查期间另有3例 interval cancer 为大细胞癌。

临床应用与阅片要点

  • 大细胞癌可表现为单发、外周、边界清楚的实性结节或肿块,边缘光滑、分叶或毛刺,阅片时需注意此类征象。
  • 对既往低剂量CT可见较小实性结节、后来快速增大的病例,应考虑到大细胞癌可能,其平均容积倍增时间约为98.7±47.8天。
  • 年度低剂量CT筛查可能漏诊生长迅速的大细胞癌,interval cancer 中也可发生大细胞癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the early radiological features and survival of Large Cell Carcinoma (LCC) cases diagnosed in low-dose computed tomography (LDCT) screening trials.

METHODS: Two radiologists jointly reviewed the radiological features of screen-detected LCCs observed in NLST, ITALUNG, and LUSI trials between 2002 and 2016, comprising a total of 29,744 subjects who underwent 3-5 annual screening LDCT examinations. Survival or causes of death were established according to the mortality registries extending more than 12 years since randomization.

RESULTS: LCC was diagnosed in 30 (4 %) of 750 subjects with screen-detected lung cancer (LC), including 15 prevalent and 15 incident cases. Three additional LCCs occurred as interval cancers during the screening period. LDCT images were available for 29 cases of screen-detected LCCs, and 28 showed a single, peripheral, and well-defined solid nodule or mass with regularly smooth (39 %), lobulated (43 %), or spiculated (18 %) margins. One case presented as hilar mass. In 9 incident LCCs, smaller solid nodules were identified in prior LDCT examinations, allowing us to calculate a mean Volume Doubling Time (VDT) of 98.7 ± 47.8 days. The overall five-year survival rate was 50 %, with a significant (p = 0.0001) difference between stages I-II (75 % alive) and stages III-IV (10 % alive).

CONCLUSIONS: LCC is a fast-growing neoplasm that can escape detection by annual LDCT screening. LCC typically presents as a single solid peripheral nodule or mass, often with lobulated margins, and exhibits a short VDT. The 5-year survival reflects the stage at diagnosis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Mascalchi M, Puliti D, Cavigli E, et al. Large cell carcinoma of the lung: LDCT features and survival in screen-detected cases. Eur J Radiol. 2024. PMID: 39163805. doi:10.1016/j.ejrad.2024.111679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。